Back

Pre-endovascular intervention C-reactive protein levels and its association with femoropopliteal artery restenosis – a systematic review and meta-analysis

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: In-stent restenosis: treatment considerations and outcomes Restenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Himanshu Rai

Mater Private Network, Dublin 7 (Ireland)

5 More presentations in this session

Presentation thumbnail
Intravascular lithotripsy versus scoring balloon for lesion preparation in underexpanded calcified in-stent restenosis treated with drug-coated balloon: an IVUS analysis
Doctor Y. Suzuki (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Long-term outcomes following DCB versus thin-strut DES for treatment of in-stent restenosis in acute coronary syndrome
Professor R. Januszek (Krakow, PL)
Abstract Slides
Presentation thumbnail
The impact of multiple stent layers on the 10-year outcomes of patients treated with percutaneous coronary intervention for in-stent restenosis
Doctor D. Lahu (DE)
Abstract Slides
Presentation thumbnail
Lesion preparation strategy before paclitaxel-coated balloon angioplasty for in-stent restenosis: a multicenter real-world study
Mr X. Qian (Beijing, CN)
Abstract Slides
Presentation thumbnail
Predictors of intravascular lithotripsy balloon rupture during percutaneous coronary intervention for severe calcified lesions
Doctor T. Kubo (Tokyo, JP)

Access the full session

Session thumbnail
In-stent restenosis: treatment considerations and outcomes

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
C-reactive protein levels and coronary in-stent restenosis: A systematic review and meta-analysis
28 August 2023
thumbnail
Congress Presentation
New biomarkers in peripheral artery disease cardiovascular rehabilitation - keep it simple
13 April 2023
thumbnail
Congress Presentation
Relation between serum levels of long acting penicillin and the inflammatory markers: High sensitivity c-reactive protein and interleukin -6 in patients with chronic rheumatic heart disease
2 September 2019
thumbnail
Congress Presentation
High-sensitivity C-Reactive protein predicts post-percutaneous coronary intervention cardiovascular risk with CKD status effect: evidence from a prospective registry study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources